Breast Cancer Clinical Trial
Using Diagnostic Tools to Stage Breast Cancer
Summary
This project is aimed at investigating the relative diagnostic and synergy of four state of the art breast imaging techniques (magnetic resonance imaging (MRI), full-field digital mammography (DMAM), ultrasound, and positron emission tomography (PET)) with respect to determining the extent of breast cancer.
Eligibility Criteria
Inclusion Criteria:
Women recently diagnosed with Breast Cancer
Will be undergoing surgery (after study) at the Hospital of the University of Pennsylvania
Exclusion Criteria:
Contraindications to MRI
previously diagnosed with breast cancer (in the smae breast) within the past 5 years
Patients with known locally advanced cancer (prior to study entry) being treated with preoperative adjuvant therapy.
Pregnant women
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Philadelphia Pennsylvania, 19104, United States
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.